These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 8792695

  • 21. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD, Cherian P, Jones RB, Vaishnavi A, Manek S, Bishop A, Polak J, Brooks A, Morris P, Thompson M, D'Silva J, Parkin S, Patterson J, Gillon KR.
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, Marino V, Hamelin B, Levine JG, Esomeprazole Study Investigators.
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [Abstract] [Full Text] [Related]

  • 23. [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
    Jeong HY, Lee BS, Sung JK, Lee TY, Yoon SJ, Kim SJ, Chung IK, Lee SH, Shin JE, Lee DS, Baek JT, Nam SW, Yoon SJ, Kim SH, Lee GS, Lee JM, Kim AN, Oh JI.
    Korean J Gastroenterol; 2006 Jan; 47(1):15-21. PubMed ID: 16434864
    [Abstract] [Full Text] [Related]

  • 24. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [Abstract] [Full Text] [Related]

  • 25. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 Feb; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 26. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993 Feb; 15(2):283-93. PubMed ID: 8100189
    [Abstract] [Full Text] [Related]

  • 27. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A, Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [Abstract] [Full Text] [Related]

  • 28. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
    Sandmark S, Carlsson R, Fausa O, Lundell L.
    Scand J Gastroenterol; 1988 Jun; 23(5):625-32. PubMed ID: 3041558
    [Abstract] [Full Text] [Related]

  • 29. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG.
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [Abstract] [Full Text] [Related]

  • 30. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, Sabesin SM, Nicholas TA.
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [Abstract] [Full Text] [Related]

  • 31. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P, Thumshirn M, Menne D, Fox M, Halim S, Fried M, Brühlmann P, Distler O, Schwizer W.
    Aliment Pharmacol Ther; 2007 Nov 01; 26(9):1259-65. PubMed ID: 17944740
    [Abstract] [Full Text] [Related]

  • 32. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
    Walan A, Bader JP, Classen M, Lamers CB, Piper DW, Rutgersson K, Eriksson S.
    N Engl J Med; 1989 Jan 12; 320(2):69-75. PubMed ID: 2643037
    [Abstract] [Full Text] [Related]

  • 33. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
    Guslandi M, Testoni PA, Passaretti S, Masci E, Ballarin E, Comin U, Marchi R, Ronchi G, Tittobello A.
    Hepatogastroenterology; 1983 Jun 12; 30(3):96-8. PubMed ID: 6309637
    [Abstract] [Full Text] [Related]

  • 34. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
    Dammann HG, Blum AL, Lux G, Rehner M, Riecken EO, Schiessel R, Wienbeck M, Witzel L, Berger J.
    Dtsch Med Wochenschr; 1986 Jan 24; 111(4):123-8. PubMed ID: 3510847
    [Abstract] [Full Text] [Related]

  • 35. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
    Swarbrick ET, Gough AL, Foster CS, Christian J, Garrett AD, Langworthy CH.
    Eur J Gastroenterol Hepatol; 1996 May 24; 8(5):431-8. PubMed ID: 8804870
    [Abstract] [Full Text] [Related]

  • 36. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL.
    Am J Gastroenterol; 2001 Nov 24; 96(11):3089-98. PubMed ID: 11721754
    [Abstract] [Full Text] [Related]

  • 37. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.
    Am J Gastroenterol; 1996 Sep 24; 91(9):1758-65. PubMed ID: 8792694
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
    Maton PN, Orlando R, Joelsson B.
    Aliment Pharmacol Ther; 1999 Jun 24; 13(6):819-26. PubMed ID: 10383513
    [Abstract] [Full Text] [Related]

  • 39. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
    Bianchi Porro G, Pace F, Peracchia A, Bonavina L, Vigneri S, Scialabba A, Franceschi M.
    J Clin Gastroenterol; 1992 Oct 24; 15(3):192-8. PubMed ID: 1479161
    [Abstract] [Full Text] [Related]

  • 40. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
    Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R.
    Arch Intern Med; 1987 Aug 24; 147(8):1485-91. PubMed ID: 3307670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.